Summary: The sodium channel gene Scn8a encodes the channel Na V 1.6, which is widely distributed in the central and peripheral nervous system. Na V 1.6 is the major channel at the nodes of Ranvier in myelinated axons. Mutant alleles of mouse Scn8a result in neurological disorders including ataxia, tremor, paralysis, and dystonia. We generated a floxed allele of Scn8a by inserting loxP sites around the first coding exon. The initial targeted allele containing the neo-cassette was a severe hypomorph. In vivo deletion of the neo-cassette by Flp recombinase produced a floxed allele that generates normal expression of Na V 1.6 protein. 
Voltage-gated sodium channels generate the rapidly rising phase of action potentials in the cell membranes of electrically excitable cells such as neurons and myocytes (Hille, 2001) . The mammalian genome contains 10 voltage-gated sodium channel genes which differ in tissue distribution, subcellular localization, and kinetic properties Yu and Catterall, 2003) . Voltage-gated sodium channel ␣ subunits are 260-kDa proteins consisting of four homologous domains each with six transmembrane segments. A positively charged transmembrane segment in each domain serves as the voltage sensor. The extracellular loops between segments five and six reenter the membrane and form the ion selectivity filter (Catterall, 2000) .
Scn8a, encoding the sodium channel protein Na V 1.6, is widely expressed in neurons throughout the central and peripheral nervous system (Burgess et al., 1995; Schaller et al., 1995) . Na V 1.6 is the primary sodium channel at the nodes of Ranvier in myelinated axons (Caldwell et al., 2000) . Additional subcellular sites of Na V 1.6 localization include axon initial segments and axons and dendrites of unmyelinated neurons (Caldwell et al., 2000; Jenkins and Bennett, 2001; Black et al., 2002; Boiko et al., 2003) . Null mutations of Scn8a in the mouse result in ataxia, tremor, and progressive paralysis with lethality by 3 weeks of age . Reduced nerve conduction in myelinated axons and failure of evoked neurotransmitter release at neuromuscular junctions of null mice result in "functional denervation" of muscle (Duchen and Stefani, 1971; Angaut-Petit et al., 1982; Kearney et al., 2002) . Electrophysiological abnormalities of cerebellar Purkinje cells, pyramidal neurons, motor neurons, the subthalamic nucleus, and the dorsal cochlear nucleus have been observed in mice deficient for Na V 1.6 (Raman et al., 1997; Chen et al., 1999; Maurice et al., 2001; Khaliq et al., 2003; Do and Bean, 2004) . The findings suggest an important physiologic role for Na V 1.6 in spontaneously firing neurons.
The hypomorphic allele Scn8a medJ reduces Scn8a mRNA and protein to 10% of normal levels (Kearney et al., 2002) . Scn8a medJ/medJ homozygotes exhibit ataxia and tremor and develop a progressive dystonic phenotype that resembles primary torsional dystonia in humans (Hamann et al., 2003) . Because the Scn8a deficiency affects many neuronal populations, the physiologic basis of the dystonia is unclear. In an effort to understand the physiologic role of Scn8a in the development of neurological disease, and to circumvent the lethality associated with complete loss of this gene, we generated mice carrying the conditional Scn8a flox allele. Scn8a is composed of 28 coding exons (Plummer et al., 1998) spanning ϳ150 kb of genomic DNA. We introduced two loxP sites to positions 107 bp upstream and 134 bp downstream of exon 1, the first coding exon. Deletion of exon 1 from the related gene Scn2a (Na V 1.2) was previously shown to produce a null allele (PlanellsCases et al., 2000) . The floxed exon and two homology arms of 5.0 kb and 0.9 kb were assembled in a vector containing a neo-cassette flanked by FRT sites (Fig. 1a) . The FRT sites were included to permit in vivo deletion of the neo-cassette if its presence interfered with expression of the targeted allele (Dymecki, 1996) .
The targeting vector was electroporated into R1 ES cells from mouse strain 129 (Nagy et al., 1993) and 480 neomycin-resistant colonies were recovered. The colonies were screened by PCR using primers F1 and R1 (Fig.  1a) . Positive colonies were confirmed by Southern blotting with a probe located upstream of the 5Ј homology arm (Fig. 1a,b) . Two homologous recombinants were obtained, 4A5 and 5A5, giving a targeting efficiency of 0.4%. Both ES cell lines were injected into B6(D2B6F1) blastocysts to produce chimeric mice. Germline transmission was obtained from 50% of the chimeric founders (9/22). Further analysis was carried out with chimeric mouse 5A5-3, which transmitted the targeted allele to 88% of his offspring.
Crossing mouse 5A5-3 to strain C57BL/6J mice generated Scn8a neo/ϩ mice heterozygous for the neo allele shown in Figure 1 . To determine whether the neo-cassette interfered with Scn8a expression, these mice were bred to homozygosity. Scn8a neo/neo mice exhibited ataxia, tremors, progressive paralysis, and lethality by 3 weeks of age. This typical Scn8a null phenotype suggested that the neo-cassette prevented gene expression, possibly due to the presence of cryptic splice donor and acceptor sites (Jacks et al., 1994) . This was confirmed by analysis of RT-PCR products obtained with a forward primer in exon 1 and a reverse primer in exon 3. Het- erozygous Scn8a neo/ϩ mice produce approximately half of the normal amount of correctly spliced transcript, and in homozygotes the transcript is dramatically reduced (Fig. 2) . In addition to the correctly spliced product, several longer RT-PCR products were obtained from Scn8a neo/ϩ and Scn8a neo/neo mice, suggesting that some of the neomycin sequence was incorporated into the transcript. The lethality of Scn8a neo/neo mice is consistent with the RT-PCR evidence that this allele is a severe hypomorph, since mice with as little as 10% of correctly spliced transcript are known to be viable (Kearney et al., 2002) .
To delete the neo-cassette from the targeted allele, chimeric mice were crossed with mice expressing Flp recombinase (Rodriguez et al., 2000) . Offspring were genotyped by amplification of genomic DNA with primers F2 and R2, shown in Figure 1 . DNA from Scn8a flox/ϩ offspring generated the 800-bp wildtype product and a 900-bp product from the floxed allele (Fig. 3a) . The floxed allele retains two lox P sites (Fig. 1) .
To evaluate the effect of the remaining loxP sites on expression of the floxed allele, the Scn8a flox/ϩ mice were intercrossed to generate Scn8a flox/flox homozygotes. Scn8a flox/flox mice are viable and did not exhibit any neurological abnormalities. A normal amount of Na V 1.6 protein was detected by Western blot of extracts from Scn8a flox/flox brains (Fig. 3b) . To determine whether deletion of exon 1 would inactivate Scn8a, homozygous Scn8a flox/flox mice were crossed with ZP3-Cre mice expressing Cre recombinase in the female germline (Lewandoski et al., 1997) . The predicted deleted allele, shown in Figure 1 , was detected in heterozygous offspring by amplification of a 300-bp fragment from genomic DNA (Fig. 3a) . Intercrosses between heterozygous Scn8a del/ϩ mice generated affected mice which exhibited ataxia by P14, followed by paralysis of the hindlimbs (Fig. 4) . The affected mice died between 3 and 4 weeks of age. All of the affected mice were homozygous for the deleted allele. The phenotype of the Scn8a del/del mice, which is characteristic of other null alleles , demonstrates successful Cre-mediated inactivation of Scn8a.
The Scn8a transcript lacking exon 1 was detected in brain by RT-PCR using a forward primer in the 5Ј UTR and a reverse primer in exon 3. A 675-bp product was obtained from wildtype RNA, while a 350-bp product was obtained from Scn8a del/del RNA (Fig. 3c) . Sequencing the RT-PCR products confirmed the absence of exon 1 from the 350-bp product and demonstrated direct splicing from the noncoding exon (NTE1) to exon 2. Analysis of protein extracts by Western blot did not detect any Na V 1.6 protein in brain of Scn8a del/del mice (Fig. 3b) .
We generated a floxed allele of Scn8a that can be inactivated by expression of Cre recombinase. The floxed allele produces normal levels of Na V 1.6 protein, and homozygotes for this allele do not exhibit neurological abnormalities. In vivo deletion of exon 1 by Cre recombinase results in complete loss of the channel protein. Mice carrying this Scn8a flox allele will be useful for dissecting the physiologic consequences of inactivating Scn8a in specific types of neurons. Conditional regulation of Scn8a inactivation will make it possible to evaluate the cognitive effects of reduced Scn8a activity in the CNS, using tests that require mice older than 3 weeks of age. Scn8a is known to be expressed at a low level in glia, but its function in these cells in not known. Crosses with a glia-specific Cre would make it possible to investigate this problem. Finally, we hope to use the floxed allele to dissect the contributions of central and peripheral nervous systems to the movement disorders that are the major abnormality in Scn8a null mice.
MATERIALS AND METHODS

Construction of the Targeting Vector
BAC clone 270F06 was isolated from a library of genomic DNA from strain 129/SvJ prepared from ES cell line RW4 (Incyte Genomics, Palo Alto, CA). PCR pools from the library were screened with primers from exon 1 of Scn8a. Three genomic fragments were used to assemble the targeting construct: a 5Ј flank (5.0 kb), an exon 1 fragment (0.5 kb), and a 3Ј flank (0.9 kb). These fragments were amplified by PCR from purified BAC DNA using the Expand High Fidelity PCR system (Roche Molecular Biochemicals, Mannheim, Germany). Each fragment was cloned into pCR-XL-TOPO vectors (Invitrogen, Carlsbad, CA). The fragment containing exon 1 was sequenced to verify that the PCR had not introduced coding or splice site mutations. The genomic fragments were excised from the pCR-XL-TOPO clones, gel purified, and sequentially ligated into the plasmid ploxP-2FRT-PGKneo (kindly provided by David Gordon, University of Colorado Health Sciences Center). A second loxP site was isolated from the plasmid pBS64 (Sauer et al., 1987) and introduced between the 5Ј homology arm and the exon fragment.
Screening ES Cells
Genomic DNA from ES cell colonies was screened by PCR using primer pair F1 (5Ј-GGA ATA GGA ACT TCG TTC TGC TCG-3Ј) in the neomycin gene and R1 (5Ј-ATG GGA CCC TGG GGA CCA CAC TTA-3Ј), located downstream of the 3Ј homology arm. Positive clones were
FIG. 3. Characterization of the Scn8a
flox and Scn8a del alleles. a: PCR of genomic DNA using primer pair F2/R2. The wildtype allele generates an 800-bp product (arrow), the floxed allele a 900-bp product, and the deleted (del) allele a 300-bp product. b: Western blot of brain protein. The blot was probed first with anti-Scn8a antibody (Na V 1.6), washed, and reprobed with anti-Scn2a antibody (Na V 1.2) as a control for protein loading. c: RT-PCR of Scn8a transcripts from brain. Primer locations are indicated. The 5Ј UTR of the Scn8a transcript is encoded by the exon designated NTE1.
analyzed by Southern blot of BamHI digested DNA, using a probe located upstream of the 5Ј homology arm (Fig. 1a) .
PCR Analyses
Floxed and deleted mice were genotyped using primer pair F2 (5Ј-GTG TGT GAT TCT CAA CAG TGG GTT-3Ј) and R2 (5Ј-GTC TGT AAG AAG GCC TGA AAG TGA-3Ј) located upstream of exon 1 and within intron 1, respectively. RT-PCR was performed with forward primer F3 in the first nontranslated exon, NTE1, (5Ј-CAC TGA GGT TTG GAC AGG TTG TCA CC-3Ј) or F4 in exon 1 (5Ј-GGA CTT TGA CCC GTA CTA TTT GAC-3Ј) and reverse primer R3 in exon 3 (5Ј-ATA CAC AGT TGG TCA GGA TGG TGC-3Ј).
Western Blot
The membrane protein fraction was isolated from brain homogenates and Western blots were carried out as described previously (Isom et al., 1995) . The blot was incubated overnight with rabbit polyclonal anti-Scn8a (1:200; Sigma, St. Louis, MO) or rabbit polyclonal antiScn2a (1:200; Sigma) followed by a 1-h incubation with a peroxidase-conjugated mouse antirabbit antibody (1: 200,000; Jackson ImmunoResearch, West Grove, PA). Signal was visualized by chemiluminescent detection with SuperSignal West Femto (Pierce, Rockford, IL).
